Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The GOLD-Study
NCT02770885Phase 2Completed
- Sponsor
- University Hospital Basel
- Start
- Mar 2016
- Primary completion
- May 2019
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of dulaglutide in primary polydipsia (PP), sponsored by University Hospital Basel. Started Mar 2016; status: completed.
02
Drugs
dulaglutide
03
Conditions
primary polydipsia (PP)
Beyond the preview
Go deeper on NCT02770885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02770885.